Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • JCI vs MRNA✓SelectedUSD · MRNAJCI vs MRNA performance historyLatest closeAs of-4.28%11/20
Stock and ETF performance explorer

JCI vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+79.2%
MRNA return
-27.3%
Excess return
+106.5%
Maximum drawdown
-42.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.3%-2.2%-2.1%-4.2%
7D-6.6%-12.7%+6.1%-6.2%
30D-13.8%-20.7%+6.9%-13.2%
3M-8.8%+46.3%-55.1%-10.0%
6M-5.0%+305.2%-310.2%-14.2%
YTD+9.7%+561.2%-551.6%-7.7%
1Y+16.2%+772.1%-755.9%-5.7%
3Y+159.7%+147.0%+12.7%+135.6%
All+79.2%-27.3%+106.5%+72.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling